APS Roadmap Scenarios: Next Step 04.30.2012
Last month we proposed ten possible Roadmap scenarios for potential future locations of programs at APS sectors. Subsequently, we received advice from APS Science Advisory Committee and Laboratory management, and feedback from our user community and APS staff. We followed up with meetings of representatives from Roadmap-affected programs and discussed the impact of various scenarios. We also performed rough cost estimates of all options and took into consideration technical limitations. After synthetizing all this input, we now propose scenario J’ as a base scenario and two of its variations (O and J) as possible options.
As before, we only list programs in this table that were considered for moving. See previous document ["Developing the APS Roadmap Scenarios"] for other programs and detailed description of scenarios development.
As the APS Upgrade moves towards creating a "baseline" for cost and schedule purposes, we encourage you to give feed back at apsroadmap@aps.anl.gov. Comments will be reviewed by a moderator and then posted.
APS Upgrade Roadmap Scenarios "Next" table Click here to download.
Main features of the base scenario Click here to download.
| Program | BASE | Option 1 | Option 2 |
| J' | O | J | |
| DCS | 35-ID | 35-ID | 35-ID |
| ISN | 32-ID-2 | 9-ID-2 | 9-ID-2 |
| MS-S | 2-ID-2 | 2-ID-2 | 2-ID-2 |
| RIXS | 27-ID | 27-ID | 27-ID |
| S3DD micro | 34-ID-2 | 34-ID-2 | 34-ID-2 |
| S3DD nano | 34-ID-1s | 34-ID-1s | 34-ID-1s |
| WFI | 20-ID | 20-ID | 20-ID |
| XIS | 28-ID | 28-ID | 28-ID |
| ASD-D | 30-ID-s | 30-ID-s | 30-ID-s |
| ASL | 25-ID | 25-ID | 25-ID |
| BCDI | 9-ID-2 | 9-ID-1 | 32-ID-2 |
| BIO | 18-ID | 18-ID | 18-ID |
| MD | 2-ID-1 | 32-ID-2 | 2-ID-1 |
| SBC | 19-ID | 19-ID | 19-ID |
| XSD LSS | 28-ID* | 28-ID* | 28-ID* |
| XSD mDiff | 34-ID-1s | 34-ID-1s | 34-ID-1s |
| XSD mFluor | 9-ID-1 | 2-ID-1 | 9-ID-1 |
- For notation n-ID-x, x denotes a cant. The use of "1" or "2" does not indicate which half of the straight section is assigned.
- Orange denotes location unchanged
- Programs in red denote difference between base scenario and options
- An "s" after the beamline designation indicates the beamline is shared with another program
- * Denotes XSD-LSS as part of XIS
| DCS–Dynamic Compression Sector | ASL–Advanced Spectroscopy/LERIX |
| ISN–In-Situ Nanoprobe | BCDI–Bragg Coherent Diffractive Imaging |
| MS–Magnetic Spectroscopy (Soft) | BIO–BIO-Cat |
| RIXS–Resonant Inelastic X-ray Scattering | MD–Magnetic Diffraction |
| S3DD–Sub-micron 3D Diffraction | SBC–SBC-CAT |
| WFI–Wide Field Imaging | XSD LSS–Liquid Surface Scattering (9-ID) |
| XIS–X-ray Interface Science | XSD mDiff–micro-Diffraction (2-ID) |
| ASD-D–ASD Diagnostics | XSD mFluor–micro-Fluorescence (2-ID-D/E) |
General Discussion | APS Roadmap Scenarios: Next Step
APS Roadmap Scenarios 03.09.2012
APS Upgrade Roadmap Scenarios table Click here to download
Goals and assumptions are given in the "Developing the APS Roadmap Scenarios" document Click here to download.
| A | B | C | D | E | F | G | H | I | J | |
| DCS | 35-ID | 35-ID | 27-ID | 28-ID | 35-ID | 35-ID | 35-ID | 35-ID | 35-ID | 35-ID |
| ISN | 2-ID-2 | 2-ID-2 | 2-ID-2 | 2-ID-2 | 9-ID-2 | 9-ID-2 | 9-ID-2 | 25-ID-2 | 9-ID-2 | 9-ID-2 |
| MS-S | 4-ID | 4-ID | 4-ID | 4-ID | 4-ID | 2-ID-2 | 25-ID-1 | 2-ID-2 | 2-ID-2 | 2-ID-2 |
| RIXS | 27-ID | 27-ID | 35-ID | 27-ID | 27-ID | 27-ID | 27-ID | 27-ID | 27-ID | 27-ID |
| S3DD micro | 34-ID-2 | 34-ID-2s | 34-ID-2s | 34-ID-2 | 34-ID-2 | 34-ID-2 | 34-ID-2 | 34-ID-2 | 34-ID-2 | 34-ID-2 |
| S3DD nano | 34-ID-1s | 34-ID-2s | 34-ID-2s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s |
| WFI | 20-ID | 20-ID | 20-ID | 19-ID | 20-ID | 20-ID | 19-ID | 19-ID | 20-ID | 20-ID |
| XIS | 28-ID | 28-ID | 28-ID | 25-ID | 28-ID | 28-ID | 28-ID | 28-ID | 28-ID | 28-ID |
| ASD-D | 30-ID | 30-ID | 30-ID | 35-ID | 30-ID | 30-ID | 30-ID | 30-ID | 30-ID | 30-ID |
| ASL | 25-ID | 25-ID | 25-ID | 20-ID | 25-ID | 25-ID | 20-ID | 20-ID | 25-ID | 25-ID |
| BCDI | 32-ID-2 | 34-ID-1s | 34-ID-1 | 32-ID-2 | 32-ID-2 | 32-ID-2 | 32-ID-2 | 32-ID-2 | 32-ID-2 | 32-ID-2 |
| BIO | 18-ID | 18-ID | 18-ID | 9-ID-2 | 18-ID | 18-ID | 9-ID-2 | 9-ID-2 | 18-ID | 18-ID |
| MD | 9-ID-1 | 9-ID-1 | 9-ID-1 | 9-ID-1 | 2-ID | 9-ID-1 | 25-ID-2 | 2-ID-1 | 2-ID-1 | 2-ID-1 |
| SBC | 19-ID | 19-ID | 19-ID | 18-ID | 19-ID | 19-ID | 18-ID | 18-ID | 19-ID | 19-ID |
| XSD LSS | 9-ID-2 | 9-ID-2 | 9-ID-2s | 15-ID-2 | 15-ID-2 | 15-ID-2 | 15-ID-2 | 15-ID-2 | 15-ID-2 | 28-ID* |
| XSD mDiff | 34-ID-1s | 34-ID-1s | 2-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s | 34-ID-1s |
| XSD mFluor | 2-ID-1 | 2-ID-1 | 2-ID-1s | 2-ID-1 | 9-ID-1 | 2-ID-1 | 2-ID | 25-ID-2 | 9-ID-1 | 9-ID-1 |
- Orange denotes location unchanged
- Yellow denotes scope reduction
- For notation n-ID-x, x denotes a cant. The use of "1" or "2" does not indicate which half of the straightsection is assigned.
- An "s" after the beamline designation indicates the beamline is shared with another program
- * Denotes XSD-LSS as part of XIS
| DCS–Dynamic Compression Sector | ASL–Advanced Spectroscopy/LERIX |
| ISN–In-Situ Nanoprobe | BCDI–Bragg Coherent Diffractive Imaging |
| MS–Magnetic Spectroscopy (Soft) | BIO–BIO-Cat |
| RIXS–Resonant Inelastic X-ray Scattering | MD–Magnetic Diffraction |
| S3DD–Sub-micron 3D Diffraction | SBC–SBC-CAT |
| WFI–Wide Field Imaging | XSD LSS–Liquid Surface Scattering (9-ID) |
| XIS–X-ray Interface Science | XSD mDiff–micro-Diffraction (2-ID) |
| ASD-D–ASD Diagnostics | XSD mFluor–micro-Fluorescence (2-ID-D/E) |
General Discussion | APS Roadmap Scenarios